Cross metathesis process
US-9512051-B2 · Dec 6, 2016 · US
US2016002147A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016002147-A1 |
| Application number | US-201414766956-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 10, 2014 |
| Priority date | Feb 8, 2013 |
| Publication date | Jan 7, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of synthesising an amino acid from an unsaturated fatty compound I that includes at least the following steps: cross-metathesis with a short unsaturated compound II, one of compounds I or II comprising a nitrile function and the other of these compounds II or I an ester function, so as to obtain and recover at least one monounsaturated nitrile ester NEU; hydrolysis of the NEU in unsaturated acid nitrile NAU; hydrogenation of the NAU to saturated amino acid AA; and then purification of the AA, if applicable, in particular by crystallisation. Also, a polymer obtained by polymerisation using the amino acid synthesised according to the method.
Opening claim text (preview).
1 . A process for synthesizing an amino acid from an unsaturated fatty compound I of formula: R1-CH═CH—[(CH 2 ) q —CH═CH] p —(CH 2 ) n —R2 in which: R1 is H, an alkyl radical of 1 to 11 carbon atoms comprising, where appropriate, a hydroxyl function, or (CH 2 ) m —R4 m is an integer in the range from 0 to 11, n is an integer in the range from 2 to 13, p is an integer, p being equal to 0, 1 or 2, q is an integer equal to 0 or 1, R2 is COOR5 or CN, R4 is H or R2R5 is an alkyl radical of 1 to 11 carbon atoms or a radical comprising two or three carbon atoms bearing one or two hydroxyl functions, or alternatively a diglyceride or a triglyceride residue in which each fatty acid of said glyceride residue is either saturated or unsaturated, wherein the process comprises at least the following steps: cross metathesis with a short unsaturated compound II, one of the compounds I or II comprising a nitrile function and the other of these compounds II or I an ester function, so as to obtain and recover at least one monounsaturated nitrile ester UNE; hydrolysis of the UNE into an unsaturated acid nitrile UAN; hydrogenation of the UAN into a saturated AA; and optional purification of the AA. 2 . The process as claimed in claim 1 , in which compound I is chosen from fatty acid esters or nitriles derived from fatty acids, chosen from: obtusilic acid (cis-4-decenoic acid) and caproleic acid (9-decenoic acid), C12 acids, lauroleic acid (cis-5-dodecenoic acid) and linderic acid (cis-4-dodecenoic acid), C14 acids, myristoleic acid (cis-9-tetradecenoic acid), physeteric acid (cis-5-tetradecenoic acid) and tsuzuic acid (cis-4-tetradecenoic acid), C16 acids, palmitoleic acid (cis-9-hexadecenoic acid), C18 acids, oleic acid (cis-9-octadecenoic acid), elaidic acid (trans-9-oxodecenoic acid), petroselinic acid (cis-6-octadecenoic acid), vaccenic acid (cis-11-octadecenoic acid) and ricinoleic acid (12-hydroxy-cis-9-octadecenoic acid), C20 acids, gadoleic acid (cis-9-eicosenoic acid), gondoic acid (cis-11-eicosenoic acid), cis-5-eicosenoic acid and lesquerolic acid (14-hydroxy-cis-11-eicosenoic acid), C22 acids, cetoleic acid (cis-11-docosenoic acid) and erucic acid (cis-13-docosenoic acid), and also the polyunsaturated acids linoleic acid and linolenic acid. 3 . The process as claimed in claim 1 , in which compound I is chosen from: CH2=CH—(CH2) n -R2, CH3-CH═CH—(CH2) n -R2, or CH3-CH2-CH═CH—(CH2) n -R2. 4 . The process as claimed in claim 1 , in which R2 is COOR5, the unsaturated short nitrile compound II being chosen from: acrylonitrile, fumaronitrile, 2-butenenitrile, 1-butenenitrile, 2-pentenenitrile, 3-pentenenitrile, 4-pentenenitrile and 1-pentenenitrile, and mixtures thereof. 5 . The process as claimed in claim 1 , in which R2 is CN, the unsaturated short ester compound II being chosen from the compounds of formula: R6-HC═CH—(CH2) n -COOR7 in which n is 0 or 1; R6 is CH3 or H; R7 is Me, Et or Bu. 6 . The process as claimed in claim 1 , in which the cross metathesis step uses at least one ruthenium-carbene catalyst chosen from the charged or uncharged catalysts of general formula: (X 1 ) a (X 2 ) b Ru(carbene C)(L 1 ) c (L 2 ) d (L 3 ) e in which: a, b, c, d and e are integers, which may be identical or different, with a and b equal to 0, 1 or 2; c, d and e equal to 0, 1, 2, 3or 4; X 1 and X 2 , which may be identical or different, each represent a charged or uncharged and monochelating or polychelating ligand; by way of example, mention may be made of halides, sulfate, carbonate, carboxylates, alkoxides, phenoxides, amides, tosylate, hexafluorophosphate, tetrafluoroborate, bis(triflyl)amide, an alkyl, tetraphenylborate and derivatives; X 1 or X 2 can be bonded to L 1 or L 2 or to the carbene C so as to form a bidentate or chelate ligand on the ruthenium; and L 1 , L 2 and L 3 , which may be identical or different, are electron-donating ligands, such as phosphine, phosphite, phosphonite, phosphinite, arsine, stilbene, an olefin or an aromatic compound, a carbonyl compound, an ether, an alcohol, an amine, a pyridine or derivative, an imine, a thioether, or a heterocyclic carbene; L 1 , L 2 or L 3 can be bonded to the carbene C so as to form a bidentate or chelate ligand, or a tridentate ligand. 7 . The process as claimed in claim 1 , wherein the process includes the use of a catalyst of formula: 8 . The process as claimed in claim 1 , wherein the metathesis step is performed in liquid medium at a temperature in the range from 20 to 160° C. and at a pressure in the range from 1 to 30 bar. 9 . The process as claimed in claim 1 , wherein the metathesis is performed in the presence of a solvent. 10 . The process as claimed in claim 1 , in which the hydrolysis step comprises at least one of the following processes: low-temperature hydrolysis in the presence of sodium hydroxide, by saponification; medium-temperature hydrolysis in solvent medium and under acidic catalysis; high-temperature hydrolysis under pressure; enzymatic hydrolysis, and mixtures thereof. 11 . The process as claimed in claim 1 , in which the hydrogenation step is performed in the presence of at least one metal catalyst chosen from ruthenium, rhodium, palladium and platinum supported on a silicon carbide support. 12 . The process as claimed in claim 1 , in which the hydrogenation temperature is in the range from 10 to 300° C. and the pressure is in the range from 1 bar to 300 bar. 13 . The process as claimed in claim 1 , in which the hydrogenation step is performed in the presence of a solvent comprising a mixture of a lower alcohol and water. 14 . The process as claimed in claim 1 , in which the hydrogenation is performed in the presence of a noble metal catalyst and of a chemical substance bearing a polydentate ligand. 15 . The process as claimed in claim 1 , in which the purification comprises at least one step of recrystallization of the product derived from the hydrogenation in an aqueous solution containing a lower aliphatic alcohol and ammonia. 16 . The process as claimed in claim 1 , in which the purification comprises at least two successive crystallization steps: (A) a step in which crude AA crystals are isolated, after dissolution of the hydrogenation product in an aqueous solution containing a lower aliphatic alcohol and an aqueous solution containing ammonia, in a first crystallization device maintained at a temperature in the range from 0 to 30° C., and (B) a step in which pure AA crystals are isolated, after redissolution of the crude AA crystals obtained in step A in an aqueous solution containing a lower aliphatic alcohol and ammonia in a second crystallization device maintained at a temperature in the range from 30 to 60° C. 17 . The process as claimed in claim 1 , also comprising a step of polyamide synthesis by polymerization using the amino acid. 18 . A polymer obtained by polymerization of the amino acid synthesized according to the process of claim 1 .
Formation of amino groups in compounds containing carboxyl groups · CPC title
by reaction of cyanides with lactones or compounds containing hydroxy groups or etherified or esterified hydroxy groups · CPC title
Alpha-amino-carboxylic acids {(polysuccinimides C08G73/1092)} · CPC title
by reactions not involving the formation of cyano groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.